Related Experiment Video
Updated: Jun 23, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Late preterm infants: severe hyperbilirubinemia and postnatal glucose homeostasis
1Department of Pediatrics, University of Louisville School of Medicine, Louisville, KY 40202, USA. ulneomed@louisville.edu
Insights
Late preterm infants, comprising most premature births, face significant health risks like hypoglycemia and hyperbilirubinemia. Recognizing their unique needs is crucial for preventing severe morbidities and mortality.
Area of Science:
- Neonatology
- Pediatrics
- Public Health
Background:
- Late preterm infants (34-36 weeks gestation) represent a significant portion of premature births.
- Historically, these infants were considered low-risk, leading to 'silent morbidity and mortality'.
- Unique physiological risks in late preterm infants were previously unrecognized, leading to suboptimal care and readmissions.
Purpose of the Study:
- To highlight the high-risk nature of late preterm infants.
- To underscore the need for recognizing specific risks, such as neonatal hypoglycemia and severe hyperbilirubinemia.
- To advocate for improved identification and management strategies for this vulnerable population.
Main Methods:
- Review of existing literature and public health data on late preterm infant outcomes.
- Analysis of common morbidities including neonatal hypoglycemia and hyperbilirubinemia.
- Comparison of care practices in Well Baby Nurseries versus specialized neonatal care.
Main Results:
- Late preterm infants experience significant, often unrecognized, health risks.
- Neonatal hypoglycemia and severe hyperbilirubinemia are common and increasing problems.
- Early discharge despite risks contributes to readmissions and severe outcomes.
Conclusions:
- Late preterm infants require specialized attention due to their unique risks.
- Improved diagnostic criteria and management protocols are essential.
- Public health initiatives are needed to address the 'silent morbidity and mortality' in this group.
Abstract:
The identification of late preterm infants as a high-risk group of infants has been an important public health breakthrough. These infants have suffered a relative 'silent morbidity and mortality' before the recognition that they have unique physiology and risks. These infants represent almost three-fourths of all premature births in the United States. Many of these infants, because of their birthweight and appearance, have been treated in Well Baby Nurseries and even discharged by 48 h of birth despite specific unidentified or unappreciated risks that have led to their readmission and possible severe morbidities or even death. Two common problems for these infants include neonatal hypoglycemia and severe hyperbilirubinemia. The definition of hypoglycemia remains controversial but is nonetheless a problem of increasing frequency in these infants.
Related Concept Videos
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Inborn Errors of Metabolism
Hyperglycemia
Diabetes Mellitus: Type 2 and Gestational
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
